Evotec SE (ETR:EVT – Get Free Report) traded down 6.9% during mid-day trading on Wednesday . The company traded as low as €4.90 and last traded at €5.12. 3,220,614 shares traded hands during trading, an increase of 137% from the average session volume of 1,360,000 shares. The stock had previously closed at €5.50.
Evotec Price Performance
The business’s 50 day moving average price is €6.13 and its 200 day moving average price is €6.49. The stock has a market capitalization of $949.62 million, a P/E ratio of -5.54, a price-to-earnings-growth ratio of 0.98 and a beta of 1.05.
Evotec Company Profile
Evotec SE operates as drug discovery and development partner for the pharmaceutical and biotechnology industry worldwide. The company is developing pharmaceutical products in various therapeutic areas, such as autoimmune diseases, cancer, CNS diseases, diabetes, fibrosis, immunology, infectious diseases, kidney diseases, liver diseases, pain and inflammation, rare diseases, respiratory diseases, tuberculosis, and women's health.
Further Reading
- Five stocks we like better than Evotec
- How to Choose Top Rated Stocks
- Market Momentum: 3 Stocks Poised for Major Breakouts
- Are These Liquid Natural Gas Stocks Ready For An Upside Bounce?
- 3 Reasons Casey’s General Stores Will Continue Trending Higher
- The 3 Best Fintech Stocks to Buy Now
- Golden Cross Alert: 3 Stocks With Major Upside Potential
Receive News & Ratings for Evotec Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Evotec and related companies with MarketBeat.com's FREE daily email newsletter.
